TG Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
25.11.24
/
50%
€34.10
Target price
25.11.25
€40.92
Performance (%)
-14.27%
Price
03.11.25
€29.24
Summary
This prediction is currently active. The price of TG Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.27%. This prediction currently runs until 25.11.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| TG Therapeutics Inc. | 1.089% | 1.089% |
| iShares Core DAX® | -0.710% | -1.054% |
| iShares Nasdaq 100 | 1.556% | 6.792% |
| iShares Nikkei 225® | 4.150% | 11.126% |
| iShares S&P 500 | 0.738% | 4.015% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread TG Therapeutics Inc. diskutieren
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $43.00. They now have an "overweight" rating on the stock.
Ratings data for TGTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for TG Therapeutics Inc.
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€29.03
03.11.25
03.11.25
€42.51
03.11.26
03.11.26
0.72%
03.11.25
03.11.25
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.95
19.04.24
19.04.24
€23.48
19.04.25
19.04.25
142.08%
20.04.25
20.04.25
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.50
01.11.23
01.11.23
€21.76
01.11.24
01.11.24
163.21%
02.11.24
02.11.24
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.89
07.08.23
07.08.23
€19.99
07.08.24
07.08.24
106.21%
08.08.24
08.08.24